Intelligent

Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs

HONG KONG,Feb. 25,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab,Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a c

02-26 Akeso, Inc.

YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)

SHANGHAI,Feb. 25,2025-- YolTech Therapeutics,a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines,today reported positive results fr

02-26 YolTech Therapeutics

Yatsen Announces Fourth Quarter and Full Year 2024 Financial Results

Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on February 25,2025 GUANGZHOU,China,Feb. 25,2025--Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG),a leading

02-26 Yatsen Holding Limited

Foxit Supercharges AI Assistant with Multi-Document Analysis on iOS & Android

Enables Users to Boost Productivity with AI-Powered Summaries,Cross-Document Insights,and Instant Data Extraction Across Mobile Device

02-26 Foxit

Vialto Partners Completes Recapitalization Transaction

Transaction Completely and Definitively Transforms Vialto\'s Capital Structure,Delivering a $225 Million New Money Equity Capital Investment in Vialto and a Reduction of Approximately $550 Million of

02-26 Vialto Partners

Axiad Applauded by Frost & Sullivan for Providing Phishing-resistant Authentication with PKI-based Authentication

Axiad\'s PKI-based authentication enables scalability and flexibility in large-scale enterprise environments,elevates user experience and streamlines user access control

02-26 Frost & Sullivan

CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China

SHANGHAI,Feb. 25,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK,"CARsgen Therapeutics"),a company focused on innovative CAR T-cell therapies for the treatment of hematolo

02-26 CARsgen Therapeutics

Keypoint Intelligence Releases New Insights on the Future of the Document Scanner Market

FAIRFIELD,N.J.,Feb. 25,2025--Keypoint Intelligence,a leading provider of digital imaging market research,has released two new reports offering critical insights for the document scanner industry: Nor

02-26 Keypoint Intelligence

MediBeacon® Transdermal GFR System receives device approval in China; Peer-reviewed articles on MediBeacon technology published

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.

02-26 MediBeacon

Risen Achieves 30.99% Efficiency with HJT-Perovskite Tandem Solar Cells!

NINGBO,China,Feb. 26,2025-- Breaking new ground in solar innovation! Risen\'sHJT (Heterojunction Technology),when combined with aperovskitecell in a tandem structure,has achieved an impressive30.99% e

02-26 Risen Energy Co., Ltd